Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758491
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell LymphomaFutureGen Biopharmaceutical (Beijing) Co., LtdNot Yet RecruitingPhase 1
NCT07758491Not Yet Recruiting
Phase 1
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Ly...FutureGen Biopharmaceutic...
NCT07758088
Dance, Yoga, And Mindful Movement Training For ASDUSC Glorya Kaufman School of DanceNot Yet RecruitingNot Applicable
NCT07758088Not Yet Recruiting
Not Applicable
Dance, Yoga, And Mindful Movement Training For ASDUSC Glorya Kaufman School...
NCT07758933
Safety of Lactobacillus LB Postbiotic in Immunocompromised Paediatric Patients With Diarrhoeal DiseaseAequitas MedicaNot Yet RecruitingPhase 1
NCT07758933Not Yet Recruiting
Phase 1
Safety of Lactobacillus LB Postbiotic in Immunocompromised Paediatric Patients W...Aequitas Medica
NCT07757711
Implementation of New Models of Ovarian Carcinoma Resistant to TherapyIstituto Europeo di OncologiaNot Yet Recruiting
NCT07757711Not Yet Recruiting
—
Implementation of New Models of Ovarian Carcinoma Resistant to TherapyIstituto Europeo di Oncol...
NCT07758153
Comparison of Sedated and Unsedated PEG in Elderly ASA IV PatientsMersin UniversityNot Yet Recruiting
NCT07758153Not Yet Recruiting
—
Comparison of Sedated and Unsedated PEG in Elderly ASA IV PatientsMersin University
NCT07758595
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's DiseaseDenali Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07758595Not Yet Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921...Denali Therapeutics Inc.
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07756801
CAPITAL OFFLOAD-SHOCKOttawa Heart Institute Research CorporationNot Yet RecruitingPhase 4
NCT07758868
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City HospitalNot Yet Recruiting
NCT07758868Not Yet Recruiting
—
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City Hospita...
NCT07757100
High-Intensity Interval Training Effects on Fitness in Youth Soccer PlayersErcüment ErdoğanCompletedNot Applicable
NCT07757100Completed
Not Applicable
High-Intensity Interval Training Effects on Fitness in Youth Soccer PlayersErcüment Erdoğan
NCT07757113
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolizationphenox Inc.Not Yet RecruitingNot Applicable
NCT07757113Not Yet Recruiting
Not Applicable
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergo...phenox Inc.
NCT07757477
Effect of Sunlight Exposure on Vitamin D Levels in Children With Cerebral PalsyIndonesia UniversityRecruitingNot Applicable
NCT07757477Recruiting
Not Applicable
Effect of Sunlight Exposure on Vitamin D Levels in Children With Cerebral PalsyIndonesia University
NCT07756957
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe AcneSanofi Pasteur, a Sanofi CompanyNot Yet RecruitingPhase 2
NCT07756957Not Yet Recruiting
Phase 2
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Modera...Sanofi Pasteur, a Sanofi...
NCT07756762
Feasibility of Pre-Conditioning FRT in SarcopeniaUniversity of HullNot Yet RecruitingNot Applicable
NCT07756762Not Yet Recruiting
Not Applicable
Feasibility of Pre-Conditioning FRT in SarcopeniaUniversity of Hull
NCT07757412
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.Odense University HospitalNot Yet RecruitingPhase 2
NCT07757412Not Yet Recruiting
Phase 2
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion...Odense University Hospita...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting5 (25%)
Completed1 (5%)
Not Specified8 (40%)
not_applicable6 (30%)
Phase 13 (15%)
Phase 22 (10%)
Phase 41 (5%)